Fiche centre
The Ohio State University
Columbus — United States
Essais liés24clinical trials
VilleColumbuslocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT03019757
Essais cliniques associés
24| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Hearo App | Insuffisance cardiaque | À vérifier | NCT06378632 | DETECT-HF — AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM | COMPLETED |
| VHB937 | Alzheimer | Phase 2 | NCT07094516 | A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease | ACTIVE_NOT_RECRUITING |
| BB-031 | Accident vasculaire cérébral | Phase 2 | NCT06226805 | Study of BB-031 in Acute Ischemic Stroke Patients (RAISE) | RECRUITING |
| WiSE System | Insuffisance cardiaque | Non applicable | NCT02922036 | SOLVE-CRT — Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients | ACTIVE_NOT_RECRUITING |
| Investigational PFO Closure Device | Accident vasculaire cérébral | Non applicable | NCT05069558 | OCCLUFLEX — Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion | ACTIVE_NOT_RECRUITING |
| Efgartigimod PH20 SC | Myopathies | Phase 3 | NCT05979441 | ALKIVIA+ — A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy | ENROLLING_BY_INVITATION |
| DaTscan | Alzheimer | À vérifier | NCT03019757 | Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease | RECRUITING |
| Electrical Impedance Myography | Myopathies | À vérifier | NCT03458832 | ReSolve — Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD | ACTIVE_NOT_RECRUITING |
| GammaTile® | Cancer | Phase 3 | NCT07195591 | BRIDGES — Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care | RECRUITING |
| Zilucoplan® | Myasthénie | Phase 3 | NCT07215949 | Zilucoplan for Severe gMG Exacerbations | RECRUITING |
| ONO-2020 | Alzheimer | Phase 2 | NCT06881836 | A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease | COMPLETED |
| NEU-411 | Parkinson | Phase 2 | NCT06680830 | NEULARK — A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease | RECRUITING |
| Medtronic Astra/Azure DR MRI IPG with AVIM therapy Activated | Hypertension | Non applicable | NCT06059638 | BACKBEAT — BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT | RECRUITING |
| Ranolazine | Sclérose latérale amyotrophique | Phase 2 | NCT06527222 | A Study of Ranolazine in ALS | RECRUITING |
| PROACTION: — Investigations of Reproductive Cancers in Women | Cancer | À vérifier | NCT06527157 | PROACTION: — Investigations of Reproductive Cancers in Women | RECRUITING |
| Magnetic Resonance Imaging-guided Focused Ultrasound Ablation (MRgFUSA) | Épilepsie | Phase 1 | NCT05032105 | The Impact of Focused Ultrasound Thalamotomy of the Anterior Nucleus for Focal-Onset Epilepsy on Anxiety | ACTIVE_NOT_RECRUITING |
| VHB937 | Sclérose latérale amyotrophique | Phase 2 | NCT06643481 | ASTRALS — A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS) | ACTIVE_NOT_RECRUITING |
| NMD670 | Myasthénie | Phase 2 | NCT06414954 | SYNAPSE-MG — Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis | RECRUITING |
| Nipocalimab | Myasthénie | Phase 3 | NCT04951622 | A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis | RECRUITING |
| Histotripsie — HistoSonics Edison System | Cancer | À vérifier | NCT06486454 | Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study) | RECRUITING |
| XEN1101 | Épilepsie | Phase 3 | NCT05667142 | X-ACKT — A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures | RECRUITING |
| Activa™ PC and Percept™ PC Neurostimulation Systems | Épilepsie | NA | NCT03900468 | Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS) | TERMINATED |
| Zilucoplan | Sclérose latérale amyotrophique | Phase 2/3 | NCT04297683 | HEALEY ALS Platform Trial - Master Protocol | ACTIVE_NOT_RECRUITING |
| eculizumab | Myasthénie | Phase 2 | NCT00727194 | Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis | TERMINATED |